The U.S. Food and Drug Administration (FDA) has approved a new generic version of fluticasone propionate. Fluticasone propionate is the medication in Flovent HFA, a daily asthma controller inhaler. The approval could help improve access and lower out-of-pocket costs for people with asthma and caregivers of children with the condition.

🗳️ Have out-of-pocket costs or insurance coverage affected your treatment choices for asthma?

Yes, significantly

Yes, somewhat

No, not really

Not sure/Something else

Thanks! You've successfully submitted your vote.

Sign up to view the results!

Continue with Facebook

Continue with Google

Continue with Email

By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.

Already a member? Log In

The approval is “an important step in expanding access to affordable asthma treatment,” according to Dr. Iilun Murphy, director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research. “Generic medications provide patients with safe, effective, and more affordable treatment options.”

What Is Fluticasone Propionate?

Fluticasone propionate is an inhaled corticosteroid, a type of medication used every day to help prevent asthma symptoms. It’s not a rescue inhaler. Instead, it works over time to reduce inflammation and swelling in the airways, making it easier to breathe and helping prevent asthma attacks.

Doctors often prescribe inhaled corticosteroids like fluticasone propionate for long-term asthma control in both adults and children.

What Makes This Generic Different?

Although the Flovent brand name was discontinued in 2024, GlaxoSmithKline continued to offer authorized generic versions of the medication. Those versions weren’t always covered by insurance and could still be expensive for some people.

The newly approved generic is made by a different company. It also went through the FDA’s generic approval process, which may help more insurance plans cover it and make it cost less.

Availability and Potential Cost Savings

The new generic version is expected to be available by prescription in the U.S. this year.

Because it’s FDA-approved, the new generic may:

• Be covered by more insurance plans
• Appear more often on lists of covered drugs
• Lower out-of-pocket costs compared to brand-name or authorized generic versions

Generics typically cost less than brand-name drugs. They contain the same active ingredients and work the same way, but they are often less expensive to produce and sell.

Why This Matters for People With Asthma

For people living with asthma or caring for children with the condition, consistent access to daily maintenance medication can make a big difference. These treatments help prevent symptoms, reduce flare-ups, and lower the risk of serious complications.

The approval of a new generic version of fluticasone propionate could mean more reliable access and lower costs, especially for those who had trouble affording or getting coverage for previous versions.

If you’re managing asthma, it may be helpful to talk with your healthcare provider about:

• Whether a generic inhaled corticosteroid is an option for you
• What medications your insurance plan covers
• How to use your inhaler correctly for the best results

Every person’s asthma is different, so treatment decisions are best made with a healthcare professional who understands your specific needs.

Join the Conversation

On MyAsthmaTeam, people share their experiences with asthma, get advice, and find support from others who understand.

How do you manage costs associated with asthma treatments? Let others know in the comments below.